LoginRegister
    Judge approves drugstore operator Brasil Pharmas bankruptcyJudge approves drugstore operator Brasil Pharma's bankruptcy
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks pleaCipla moves against NPPA for price fixation of asthma drugs; DOP junks plea
    Laurus Labs gets 2 USFDA observations for its API facilities in VisakhapatnamLaurus Labs gets 2 USFDA observations for its API facilities in Visakhapatnam
    Novartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing DirectorNovartis India appoints Sanjay Murdeshwar as Vice Chairman, Managing Director
    Merck Foundation, First Lady of Guinea enters partnership to build healthcare capacity, break infertility stigmaMerck Foundation, First Lady of Guinea enters partnership to build healthcare capacity, break...
    China province eyeing investment opportunities in Indian medical sectorChina province eyeing investment opportunities in Indian medical sector
    Counterfeit medicines costing pharmaceutical industry billions each year: ReportCounterfeit medicines costing pharmaceutical industry billions each year: Report
    Positive New for Sun Pharma- Promising Phase 2 study results of inhibitor ILUMYA reportedPositive New for Sun Pharma- Promising Phase 2 study results of inhibitor ILUMYA reported
    Zydus gets USFDA nod for Omega-3-Acid Ethyl Esters capsulesZydus gets USFDA nod for Omega-3-Acid Ethyl Esters capsules
    Biocon gets European nod for biologics facilities in BengaluruBiocon gets European nod for biologics facilities in Bengaluru
    Data integrity lapse at Aurobindo Pharma Bachupally Unit, says USFDAData integrity lapse at Aurobindo Pharma Bachupally Unit, says USFDA
    Dr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approxDr Reddys to sell Tosymra, Zembrace to Upsher-Smith Labs for Rs 765 crore approx
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X